<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To ascertain the clinical presentation, histopathology and outcome of renal involvement in patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS), <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> secondary to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SAPS) and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> alone </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: A retrospective analysis was undertaken of 20 patients with PAPS, 25 patients with SAPS and 275 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> to ascertain the frequency and pattern of renal involvement </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Renal involvement was found most frequently in patients with SAPS, in whom it occurred in 68% of patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Renal disease</z:e> was equally common in patients with PAPS and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> alone where it was seen in 30% of patients </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> most frequently presented with <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> due to <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo>, whereas those with PAPS and SAPS were more likely to present with <z:hpo ids='HP_0000822'>hypertension</z:hpo> and reduced glomerular filtration rate </plain></SENT>
<SENT sid="5" pm="."><plain>No patients with PAPS developed <z:hpo ids='HP_0003774'>end-stage renal failure</z:hpo> compared with 5.9% of patients with SAPS and 16.9% of patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> alone; 23.5% of patients with SAPS died compared with 15.7% of patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> alone and no patients with PAPS </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Renal involvement is a major feature of both PAPS and SAPS, where <z:mp ids='MP_0011507'>renal thrombosis</z:mp> frequently leads to reduced glomerular filtration rate and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>One-third of patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> alone develop <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> leading to <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> which most commonly presents with <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with PAPS were less likely to develop <z:hpo ids='HP_0003774'>end-stage renal failure</z:hpo> or die during the follow-up period </plain></SENT>
</text></document>